Financials
- Market Capitalization 471.88 M
- Employee 102
- Founded 2010
- CEO Brian Stuglik
- Website www.verastem.com
- Headquarter Massachusetts, United States
- FIGI BBG001J2LSK5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.1
市销率
8.5
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2951 | OCGN Ocugen, Inc. - Common Stock | 1.41 USD | -4.08% | -6.62% | +11.02% | +25.89% | 477.32 M USD | ||
| 2960 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 7.77 USD | -8.48% | -14.99% | -5.47% | +75.79% | 472.38 M USD | ||
| 2974 | PRTA Prothena Corporation plc - Ordinary Shares | 8.83 USD | -4.44% | -8.21% | +0.68% | +37.11% | 462.28 M USD | ||
| 2977 | STRO Sutro Biopharma, Inc. - Common Stock | 27.84 USD | -6.36% | -10.19% | -3.33% | +60.09% | 461.32 M USD |